Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Retained Earnings (2016 - 2020)

Larimar Therapeutics (LRMR) has disclosed Retained Earnings for 7 consecutive years, with $41000.0 as the latest value for Q3 2019.

  • For the quarter ending Q3 2019, Retained Earnings rose 100.01% year-over-year to $41000.0, compared with a TTM value of $41000.0 through Sep 2019, up 100.01%, and an annual FY2018 reading of -$33000.0, up 99.99% over the prior year.
  • Retained Earnings was $41000.0 for Q3 2019 at Larimar Therapeutics, up from $30000.0 in the prior quarter.
  • Across five years, Retained Earnings topped out at $41000.0 in Q3 2019 and bottomed at -$364.1 million in Q1 2019.
  • Average Retained Earnings over 5 years is -$148.3 million, with a median of -$156.5 million recorded in 2015.
  • The sharpest move saw Retained Earnings tumbled 1884950.0% in 2017, then soared 100.01% in 2019.
  • Year by year, Retained Earnings stood at -$207000.0 in 2015, then tumbled by 114657.97% to -$237.5 million in 2016, then decreased by 21.9% to -$289.6 million in 2017, then surged by 99.99% to -$33000.0 in 2018, then skyrocketed by 224.24% to $41000.0 in 2019.
  • Business Quant data shows Retained Earnings for LRMR at $41000.0 in Q3 2019, $30000.0 in Q2 2019, and -$364.1 million in Q1 2019.